Insider · CIK 0002049375
Abizer Gaslightwala
directorceoofficerpresident
Files at AKTX (Akari Therapeutics Plc). First filing Jun 20, 2025, latest Aug 29, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
4 / 0
$57k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AKTX: Akari Therapeutics Plc
AKTXOct 9, 2026 · close 8.77
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | AKTXbuy Akari Therapeutics Plc | $20k 21,000 shares | +8% | +6% from low-74% from high | |
| 30Weak | AKTXbuy Akari Therapeutics Plc | $7,120 6,146 shares | +2% | - | |
| 30Weak | AKTXbuy Akari Therapeutics Plc | $12k 10,000 shares | +4% | - | |
| 28Weak | AKTXbuy Akari Therapeutics Plc | $18k 15,000 shares | +6% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | AKTX Akari Therapeutics Plc | AGrant or award American Depositary Shares representing Ordinary Shares | +6,430 | $9.72 | $62k | 14,107 | 11 d ago |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | POpen-market purchase Warrants to purchase American Depositary Shares ("ADRs")derivative | +309,328 | - | - | 309,328 | Dec 18, 2025 |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | POpen-market purchase Pre-Funded Warrants to purchase ADRsderivative | +309,328 | $0.40 | $125k | 309,328 | Dec 18, 2025 |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | POpen-market purchase Warrants to purchase ADRsderivative | +773,323 | - | - | 773,323 | Dec 18, 2025 |
| Dec 16, 2025 | AKTX Akari Therapeutics Plc | POpen-market purchase Pre-Funded Warrants to purchase ADRsderivative | +773,323 | $0.40 | $312k | 773,323 | Dec 18, 2025 |
| Aug 21, 2025 | AKTX Akari Therapeutics Plc | POpen-market purchase American Depositary Shares representing Ordinary Shares | +10,000 | $0.94 | $9,400 | 287,574 | Aug 29, 2025 |
| Aug 22, 2025 | AKTX Akari Therapeutics Plc | POpen-market purchase American Depositary Shares representing Ordinary Shares | +8,000 | $0.93 | $7,440 | 295,574 | Aug 29, 2025 |
| Aug 25, 2025 | AKTX Akari Therapeutics Plc | POpen-market purchase American Depositary Shares representing Ordinary Shares | +3,000 | $0.90 | $2,700 | 298,574 | Aug 29, 2025 |
| Jun 23, 2025 | AKTX Akari Therapeutics Plc | POpen-market purchase American Depositary Shares representing Ordinary Shares | +943 | $1.15 | $1,084 | 272,371 | Jun 25, 2025 |
| Jun 24, 2025 | AKTX Akari Therapeutics Plc | POpen-market purchase American Depositary Shares representing Ordinary Shares | +5,203 | $1.16 | $6,035 | 277,574 | Jun 25, 2025 |
| Jun 20, 2025 | AKTX Akari Therapeutics Plc | POpen-market purchase American Depositary Shares representing Ordinary Shares | +10,000 | $1.20 | $12k | 271,428 | Jun 24, 2025 |
| Jun 17, 2025 | AKTX Akari Therapeutics Plc | POpen-market purchase American Depositary Shares representing Ordinary Shares | +15,000 | $1.20 | $18k | 261,428 | Jun 20, 2025 |
| Jun 12, 2025 | AKTX Akari Therapeutics Plc | AGrant or award American Depositary Shares representing Ordinary Shares | +20,000 | $1.23 | $25k | 221,428 | Jun 16, 2025 |
| Jun 13, 2025 | AKTX Akari Therapeutics Plc | AGrant or award American Depositary Shares representing Ordinary Shares | +25,000 | $1.19 | $30k | 246,428 | Jun 16, 2025 |
| Jun 10, 2025 | AKTX Akari Therapeutics Plc | AGrant or award American Depositary Shares representing Ordinary Shares | +20,000 | $1.27 | $25k | 201,428 | Jun 12, 2025 |
| Mar 20, 2025 | AKTX Akari Therapeutics Plc | AGrant or award Stock Option (Right to Buy)derivative | +1,100,000 | $0.00 | $0 | 1,100,000 | Mar 24, 2025 |
| Mar 20, 2025 | AKTX Akari Therapeutics Plc | AGrant or award Stock Option (Right to Buy)derivative | +600,000 | $0.00 | $0 | 600,000 | Mar 24, 2025 |
| Mar 6, 2025 | AKTX Akari Therapeutics Plc | AGrant or award American Depositary Shares representing Ordinary Shares | +133,928 | $1.12 | $150k | 181,428 | Mar 10, 2025 |
| Mar 6, 2025 | AKTX Akari Therapeutics Plc | AGrant or award Series A Warrants (Right to Buy)derivative | +133,928 | $1.12 | $150k | 133,928 | Mar 10, 2025 |
| Mar 6, 2025 | AKTX Akari Therapeutics Plc | AGrant or award Series B Warrants (Right to Buy)derivative | +133,928 | $1.12 | $150k | 133,928 | Mar 10, 2025 |
| Jan 10, 2025 | AKTX Akari Therapeutics Plc | AGrant or award American Depository Shares representing Ordinary Shares | +11,439 | $1.22 | $14k | 35,860 | Jan 13, 2025 |
| Jan 3, 2025 | AKTX Akari Therapeutics Plc | AGrant or award Ordinary Shares, par value $0.0001 per share | +1,720,000 | $0.00 | $1,032 | 71,720,000 | Jan 7, 2025 |
| Dec 27, 2024 | AKTX Akari Therapeutics Plc | AGrant or award Ordinary Shares, par value $0.0001 per share | +40,000,000 | $0.00 | $20k | 70,000,000 | Dec 30, 2024 |
| Dec 26, 2024 | AKTX Akari Therapeutics Plc | AGrant or award Ordinary Shares, par value $0.0001 per share | +30,000,000 | $0.00 | $15k | 30,000,000 | Dec 27, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.